Diffuse pigmented villonodular synovitis incidentally identified during revision total knee arthroplasty for aseptic loosening: a case report Authors: Tae-hun Lee, Yong-sik Lee, Gil-yeong Ahn, Jee-soo Park, Se-ik Shin Published: 2026 ABSTRACT AbstractBackgroundPigmented villonodular synovitis (PVNS) occurring after total knee arthroplasty (TKA) is extremely rare and has most commonly been reported within 10 years after the index procedure. Clinically, it can be difficult to distinguish from polyethylene wear–induced synovitis or aseptic loosening. We report a rare case of diffuse PVNS diagnosed 21 years after primary TKA and treated with revision arthroplasty.Case presentationA 71-year-old man presented with a one-year history of left knee pain. He had undergone primary TKA 21 years earlier and maintained excellent function with full weight-bearing and unrestricted daily activities for approximately 20 years after surgery. Following this long asymptomatic period, the patient developed knee swelling and recurrent hemarthrosis, which was confirmed on three occasions by joint aspiration.Radiographic and computed tomography (CT) evaluations suggested aseptic loosening of the tibial component accompanied by extensive osteolysis on the medial side of the proximal tibia. During revision surgery, diffuse synovial hypertrophy characterized by yellowish-brown papillary projections was observed. Complete synovectomy and revision arthroplasty were performed. Histopathological examination subsequently confirmed diffuse PVNS.ConclusionsWe report a rare case of diffuse PVNS confirmed by surgical biopsy during revision arthroplasty performed 21 years after primary TKA, representing an unusually long interval after the index procedure. In patients with TKA presenting with recurrent hemarthrosis and aseptic loosening, PVNS should be considered in the differential diagnosis and may be associated with prosthetic loosening.Keywords: Knee Joint, Total Knee Arthroplasty, Hemarthrosis, Aseptic loosening, Pigmented Villonodular Synovitis Background Pigmented villonodular synovitis (PVNS) is a rare, benign proliferative disorder of the synovium that most commonly affects the knee joint, although it can occur in any synovial joint [1]. The exact etiology remains unclear, but several mechanisms have been proposed, including repetitive trauma, recurrent hemarthrosis, abnormal synovial cell proliferation, and neoplastic processes. Clinically, PVNS is generally classified into localized and diffuse forms [2, 3]. Although uncommon, PVNS has been reported after total knee arthroplasty (TKA), where it is thought to represent reactive synovial proliferation associated with polyethylene wear debris from prosthetic components [4]. In the evaluation of TKA failure, the high prevalence of aseptic loosening may lead clinicians to overlook rare underlying pathologies such as PVNS. Furthermore, PVNS occurring after TKA is often difficult to distinguish clinically and radiologically from polyethylene wear–induced synovitis, which may delay diagnosis [5]. Previous studies have suggested that PVNS after TKA is typically diagnosed within approximately nine years after the index procedure [5, 6]. In this report, we describe a rare case of diffuse PVNS associated with recurrent hemarthrosis that was diagnosed 21 years after primary TKA. Case presentation A 71-year-old man presented with a one-year history of left knee pain. He had undergone primary total knee arthroplasty (TKA) for osteoarthritis 21 years earlier at another institution. No medical records indicated evidence of PVNS in the synovium at the time of the initial surgery, and no postoperative findings suggestive of PVNS had been reported. The function of the affected knee remained excellent for approximately 20 years after surgery, allowing full weight-bearing and unrestricted daily activities. After this prolonged asymptomatic period, the patient developed recurrent knee swelling and joint effusion. Arthrocentesis was performed on three occasions, each confirming hemarthrosis, and the patient was referred to our institution for further evaluation. On physical examination, tenderness, swelling, and limited range of motion of the knee joint (0–80°) were observed. The patient had no history of trauma or infection. Laboratory tests, including C-reactive protein, erythrocyte sedimentation rate, and rheumatoid factor, were within normal limits. Plain radiographs demonstrated a radiolucent line (> 2 mm) beneath the medial aspect of the tibial component, with slight subsidence of the prosthesis, raising suspicion of prosthetic loosening (Fig. 1). Computed tomography (CT) with metal artifact reduction revealed marked osteolytic changes confined to the medial tibial condyle adjacent to the prosthesis (Fig. 2). Based on these findings, aseptic loosening of the tibial component was diagnosed, and revision TKA was performed. A Anteroposterior (AP) knee radiograph shows an osteolytic lesion on the medial tibial condyle (white arrow), and (B) lateral view demonstrates radiolucent line (> 2 mm) at the implant-cement interface (white arrow) Coronal computed tomography (CT) reconstruction image shows periprosthetic osteolysis in the medial tibial plateau (white arrow) Intraoperatively, extensive diffuse synovial hypertrophy characterized by yellowish-brown papillary projections and nodules was unexpectedly observed around the prosthesis. The tibial component was loosened from the tibial metaphysis and was associated with bone defects in the proximal tibia and severe wear of the polyethylene liner. After complete synovectomy (Fig. 3), revision TKA was performed using the Vanguard SSK Revision Knee System (Zimmer Biomet, Warsaw, IN, USA), consisting of a femoral component, an I-Beam tibial tray, and a 14-mm polyethylene insert (Fig. 4). Gross photograph shows the excised synovium, which appears as a firm, grey-yellowish tissue A Postoperative anteroposterior (AP) radiograph and (B) lateral radiograph show the knee status after revision total knee arthroplasty Gross examination of the resected synovium revealed villonodular fronds on the surface. Histopathological examination with hematoxylin–eosin (H&E) staining demonstrated characteristic villonodular architecture surrounded by hyperplastic synovial tissue at low magnification (×40) (Fig. 5A). Papillary projections and hypercellular nodular synovium were also observed (Fig. 5B). At higher magnification (×200), the lesion consisted predominantly of mononuclear histiocytoid cells with scattered multinucleated giant cells (Fig. 6A). Numerous foamy histiocytes and hemosiderin-laden macrophages were also identified throughout the tissue (Fig. 6B), confirming the diagnosis of diffuse PVNS. Pathologic findings. A Hematoxylin and eosin (H&E) stain (×40). It shows exuberant villonodular fronds with overlying synovial tissue. B Hematoxylin and eosin (H&E) stain (×40). It reveals nodular hyperplastic synovium with papillary projection and high cellularity A Hematoxylin and eosin (H&E) stain (×200). It shows that the tumor tissue is composed of abundant mononuclear histiocytoid cells, admixed with multinucleated giant cells. B Hematoxylin and eosin (H&E) stain (×200). It reveals many foamy histiocytes (white dotted line) and hemosiderin-containing macrophages. (yellow dotted line) Discussion Pigmented villonodular synovitis (PVNS) is a proliferative disorder of the synovial membrane characterized by excessive synovial hyperplasia and hemosiderin deposition. Although its exact pathogenesis remains uncertain, it has been described as either an inflammatory or neoplastic process and may present in localized or diffuse forms. PVNS is known for its locally aggressive behavior and relatively high recurrence rate, which are important considerations in clinical management [3, 7]. PVNS occurring after arthroplasty is rare but has been reported as a potential cause of persistent synovitis, recurrent hemarthrosis, and implant failure. However, only a limited number of cases have been described in the literature, and most were diagnosed within approximately 10 years after the index arthroplasty [4, 5, 8, 9]. The present case represents an unusually delayed presentation of PVNS, diagnosed more than two decades after the primary total knee arthroplasty. The patient maintained satisfactory clinical function for nearly 20 years after the initial procedure before developing recurrent hemarthrosis during the year preceding presentation. Such a prolonged asymptomatic interval highlights the potential for late-onset synovial pathology after arthroplasty. A period of two decades after total knee arthroplasty is sufficient for polyethylene wear to occur. Xu et al. [10] suggested that polyethylene wear particles can activate macrophages and induce chronic synovial inflammation through the CSF1/CSF1R signaling pathway, ultimately contributing to periprosthetic osteolysis and implant loosening. In the present case, it is plausible that chronic synovial changes associated with polyethylene wear particles gradually developed over the 20-year period, although the progression may have remained clinically silent. Nevertheless, the precise relationship between PVNS and the inflammatory process remains uncertain. It is unclear whether chronic synovitis associated with wear particles led to recurrent hemarthrosis and subsequently contributed to the development of PVNS, or whether PVNS developed first and resulted in recurrent hemarthrosis. Therefore, the direct causal relationship between these processes remains speculative, and further large-scale studies are required to clarify this association. Based on the findings of this case, routine synovial biopsy during revision total knee arthroplasty may be helpful when implant loosening is suspected. Histopathological evaluation may reveal synovial abnormalities, including chronic synovitis, foreign-body reactions induced by microscopic polyethylene wear particles, and proliferative synovial disorders such as PVNS. Panciera et al. [11] reported that patients with PVNS undergoing total knee arthroplasty have a higher risk of postoperative complications, suggesting that the intrinsic proliferative nature of PVNS may contribute to implant loosening. Although the overall diagnostic yield of routine synovial biopsy during arthroplasty has been reported to be relatively low [12], such evaluation may still provide valuable information regarding synovial pathology and facilitate the identification of uncommon conditions such as PVNS. Conclusion This case highlights an exceptionally delayed presentation of pigmented villonodular synovitis more than two decades after primary total knee arthroplasty. In patients with TKA who develop recurrent hemarthrosis or unexplained synovitis, PVNS should be considered in the differential diagnosis. Furthermore, synovial biopsy during revision arthroplasty may help identify proliferative synovial disorders that might otherwise remain unrecognized. Acknowledgements Not applicable. Informed consent Was obtained from all participants, and the study protocol was approved by the appropriate institutional review board, following the guidelines of the Declaration of Helsinki. Abbreviations Pigmented villonodular synovitis Total knee arthroplasty Computed tomography Authors’ contributions YS Lee, TH Lee and JS Park wrote the main manuscript text. JS Park prepared all figures. SI Shin, YS Lee and GY Ahn conducted the final review and revision. Funding This research did not receive any external fundings. Data availability The datasets analyzed during the current study are available from the corresponding author upon request. Declarations Ethics approval and consent to participate This study is a retrospective case report involving a human subject. Since this study involved the retrospective review of medical records without any additional examinations, procedures, or data collection for research purposes, it was exempted from review by the Institutional Review Board (IRB). Written informed consent was obtained from the patient for the use of their medical records, including clinical information, imaging studies, and histological results. Consent for publication We confirm that written informed consent was obtained from the participant(patient) for the use of clinical information(personal & clinical details along with any identifying images) within the scope that does not compromise their anonymity. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The datasets analyzed during the current study are available from the corresponding author upon request.